TD Cowen on Boston Scientific (BSX): 'remains our top pick'

TD Cowen analyst Joshua Jennings reiterated a Buy rating and $115.00 price target on Boston Scientific (NYSE: BSX).

The analyst comments "Our visit to BSX HQ revived the conviction we felt at last week's investor day. We covered ample ground in PFA and got answers that again suggest BSX's outlook is very compelling despite new competition. CEO Mike Mahoney also gave thoughtful replies to various growth questions that underscored his focus on category leadership, including as a means for contracting success. BSX remains our top pick."

For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.

Shares of Boston Scientific closed at $97.28 yesterday.

You May Also Be Interested In

• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• Terreno Realty Corp (TRNO) PT Raised to $77 at Cantor Fitzgerald on Leasing Optimism
• Axe Compute and Duos Technologies agree on 55 MW AI data center deal